SCHEMBL21048419

SCHEMBL21048419

O=P(O)(O)C[S+]([O-])c1nnnn1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.45
MAPT P10636 4/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PKM P14618 3/20 0.41
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD11B1 P28845 2/20 0.39
HTT P42858 2/20 0.38
CCR6 P51684 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19822540 0.81 ALDH1A1 (0.43) ALDH1A1MAPTPOLBMEN1KMT2A
Phosphoric Acid SCHEMBL28004344 0.68 ALDH1A1 (0.45) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL17045185 0.68 MEN1 (0.39) ALDH1A1MEN1KMT2ATSHRCYP2C19
SCHEMBL18911558 0.68 MEN1 (0.39) ALDH1A1MEN1KMT2ATSHRCYP2C19
SCHEMBL7305467 0.68 ELANE (0.64) NPC1RAB9A
SCHEMBL2210882 0.63 HSD11B1 (0.59) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL54976 0.63 ALDH1A1 (0.53) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL54977 0.63 ALDH1A1 (0.53) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL97009 0.62 HTT (0.60) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL2211636 0.62 ALDH1A1 (0.53) ALDH1A1MAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10315990-B2 Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof DRIVINGFORCE THERAPEUTICS (CN) 2019-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10315990-B2 Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof XPO1, XPOT, XPO4 ALDH1A1 3282/4885MAPT 2520/4885POLB 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.